Skip to main content
Fig. 1 | BMC Psychiatry

Fig. 1

From: Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C

Fig. 1

The proportion of depression (a) and anxiety (b) among patients during a combination treatment with interferon and ribavirin at the baseline, week 4, 12 and 24. Note: Group 1, patients who received antiviral treatment with PegIFN-α-2a plus ribavirin; Group 2, patients who received antiviral treatment with PegIFN-α-2b plus ribavirin. There were no significant differences in the proportion of depression or anxiety between the two groups at any time-point. *p < 0.05 in comparison to the proportion at baseline

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us